OBJECTIVE: Currently, no practical biomarker is available for the diagnosis of acute ischemic stroke. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) has being applied extensively to analyze large biomolecules such as proteins. The technique is likely to be of remarkable value as indicators of systemic processes such as atherosclerosis and stroke. The aim of this study is to identify potential protein biomarkers for ischemic stroke diagnosis utilizing MALDI-TOF MS. METHODS: Serum samples obtained from acute ischemic stroke patients (n = 47) and controls (n = 34) were analyzed by MALDI-TOF MS. Stroke severity was assessed by the National Institutes of Health Stroke Scale (NIHSS), subtype by the Trial of Org 10172 in Acute Stroke Treatment (TOAST), functional outcome by the modified Rankin Scale (mRS) and infarct volume by the diffusion-weighted images. Risk factors and routine laboratory data of the stroke patients were registered prospectively. RESULTS: The peaks of hemoglobin (Hb) alpha-chain and beta-chain were differentially expressed between stroke patients and controls (p < 0.0001). Hb ions were detected in the samples collected from 33 (70.2%) stroke patients and 5 (14.7%) controls. The sensitivity is 70.2% and the specificity is 85.3%. Among stroke patients, there is no significant correlation (p > 0.05) between Hb peaks and the NIHSS, TOAST, mRS, stroke risk factors, infarct volume, infarct location and laboratory data. CONCLUSIONS: Serum free Hb may serve as a novel potential biomarker for the diagnosis of acute ischemic stroke. The clinical value of this potential biomarker may be clarified by further studies quantifying serum free Hb levels.
OBJECTIVE: Currently, no practical biomarker is available for the diagnosis of acute ischemic stroke. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) has being applied extensively to analyze large biomolecules such as proteins. The technique is likely to be of remarkable value as indicators of systemic processes such as atherosclerosis and stroke. The aim of this study is to identify potential protein biomarkers for ischemic stroke diagnosis utilizing MALDI-TOF MS. METHODS: Serum samples obtained from acute ischemic strokepatients (n = 47) and controls (n = 34) were analyzed by MALDI-TOF MS. Stroke severity was assessed by the National Institutes of Health Stroke Scale (NIHSS), subtype by the Trial of Org 10172 in Acute Stroke Treatment (TOAST), functional outcome by the modified Rankin Scale (mRS) and infarct volume by the diffusion-weighted images. Risk factors and routine laboratory data of the strokepatients were registered prospectively. RESULTS: The peaks of hemoglobin (Hb) alpha-chain and beta-chain were differentially expressed between strokepatients and controls (p < 0.0001). Hb ions were detected in the samples collected from 33 (70.2%) strokepatients and 5 (14.7%) controls. The sensitivity is 70.2% and the specificity is 85.3%. Among strokepatients, there is no significant correlation (p > 0.05) between Hb peaks and the NIHSS, TOAST, mRS, stroke risk factors, infarct volume, infarct location and laboratory data. CONCLUSIONS: Serum free Hb may serve as a novel potential biomarker for the diagnosis of acute ischemic stroke. The clinical value of this potential biomarker may be clarified by further studies quantifying serum free Hb levels.
Authors: Ahn Woong-Shick; Park Sung-Pil; Bae Su-Mi; Lee Joon-Mo; Namkoong Sung-Eun; Nam Gye-Hyun; Cho Young-Lae; Choi Ho-Sun; Jun Heung-Jae; Kim Chong-Kook; Kim Young-Wan; Han Byoung-Don; Jin Hyun-Sun Journal: Cancer Sci Date: 2005-03 Impact factor: 6.716
Authors: Michael T Wunderlich; Thorsten Hanhoff; Michael Goertler; Friedrich Spener; Jane F C Glatz; Claus-W Wallesch; Maurice M A L Pelsers Journal: J Neurol Date: 2005-04-18 Impact factor: 4.849
Authors: Katherine R Kozak; Malaika W Amneus; Suzanne M Pusey; Feng Su; Mui N Luong; Sam A Luong; Srinivasa T Reddy; Robin Farias-Eisner Journal: Proc Natl Acad Sci U S A Date: 2003-10-01 Impact factor: 11.205
Authors: Marie Dagonnier; Ira Robin Cooke; Pierre Faou; Tara Kate Sidon; Helen Margaret Dewey; Geoffrey Alan Donnan; David William Howells Journal: Biomark Insights Date: 2017-12-20
Authors: Grant C O'Connell; Ashley B Petrone; Madison B Treadway; Connie S Tennant; Noelle Lucke-Wold; Paul D Chantler; Taura L Barr Journal: NPJ Genom Med Date: 2016-11-30 Impact factor: 8.617
Authors: Grant C O'Connell; Connie S Tennant; Noelle Lucke-Wold; Yasser Kabbani; Abdul R Tarabishy; Paul D Chantler; Taura L Barr Journal: Sci Rep Date: 2017-10-11 Impact factor: 4.379
Authors: Aleksandra Turek-Jakubowska; Janusz Dębski; Maciej Jakubowski; Ewa Szahidewicz-Krupska; Jakub Gawryś; Karolina Gawryś; Agnieszka Janus; Małgorzata Trocha; Adrian Doroszko Journal: J Clin Med Date: 2022-01-11 Impact factor: 4.241